Presence and meaning of anti‐HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers
Peter Kryger, Lars R. Mathiesen, Jan Aldershvile, Jens O. Nielsen, The Copenhagen Hepatitis Acuta Programme – 1 May 1981 – To evaluate the clinical implication of IgM antibody against hepatitis B core antigen (anti‐HBc IgM), a consecutive series of 87 patients with acute type B hepatitis and 16 healthy carriers of hepatitis B surface antigen (HBsAg) were studied by a newly developed reverse ELISA technique.